Hervé Dombret

1.9k total citations
14 papers, 500 citations indexed

About

Hervé Dombret is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hervé Dombret has authored 14 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Molecular Biology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hervé Dombret's work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and Retinoids in leukemia and cellular processes (6 papers). Hervé Dombret is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and Retinoids in leukemia and cellular processes (6 papers). Hervé Dombret collaborates with scholars based in France, Belgium and Australia. Hervé Dombret's co-authors include Norbert Vey, X. Thomas, Nathalie Contentin, A. Etienne, Thierry de Revel, Claude Gardin, Pascal Turlure, Sophie Rigaudeau, Christine Terré and Dominique Bordessoule and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Molecular Sciences.

In The Last Decade

Hervé Dombret

14 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hervé Dombret France	12	389	221	195	91	79	14	500
Maria Grazia Cocito Italy	8	247 0.6×	162 0.7×	146 0.7×	36 0.4×	50 0.6×	15	336
Sherry Pierce United States	4	262 0.7×	222 1.0×	104 0.5×	72 0.8×	58 0.7×	5	342
Ansu Abu Alex India	9	202 0.5×	94 0.4×	150 0.8×	68 0.7×	32 0.4×	22	334
Mariacarla De Simone Italy	11	252 0.6×	83 0.4×	210 1.1×	74 0.8×	39 0.5×	14	384
TS Gee United States	6	465 1.2×	188 0.9×	235 1.2×	59 0.6×	83 1.1×	8	509
Michael J. Keating United States	9	292 0.8×	103 0.5×	120 0.6×	96 1.1×	104 1.3×	10	400
M. de Jesús Gallegos Santiago Spain	9	164 0.4×	62 0.3×	146 0.7×	57 0.6×	67 0.8×	11	334
S. Fenu Italy	9	301 0.8×	86 0.4×	127 0.7×	45 0.5×	54 0.7×	20	367
Hui-liang Xue China	10	158 0.4×	184 0.8×	138 0.7×	60 0.7×	29 0.4×	54	395
Jackie Fiorentino United States	6	477 1.2×	90 0.4×	612 3.1×	65 0.7×	46 0.6×	7	703

Countries citing papers authored by Hervé Dombret

Since Specialization

Citations

This map shows the geographic impact of Hervé Dombret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Dombret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Dombret more than expected).

Fields of papers citing papers by Hervé Dombret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Dombret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Dombret. The network helps show where Hervé Dombret may publish in the future.

Co-authorship network of co-authors of Hervé Dombret

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Dombret. A scholar is included among the top collaborators of Hervé Dombret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Dombret. Hervé Dombret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Fenwarth, Laurène, Élise Fournier, Meyling Cheok, et al.. (2020). Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment. International Journal of Molecular Sciences. 21(16). 5626–5626. 17 indexed citations

Prébet, Thomas, Sarah Bertoli, Xavier Thomas, et al.. (2014). Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup. Blood. 124(8). 1312–1319. 58 indexed citations

Vey, Norbert, Hervé Dombret, Norbert Ifrah, et al.. (2013). Intergroup ALFA/GOELAMS randomized phase II trial of lirilumab anti-KIR monoclonal antibody (IPH2102/BMS986015) as maintenance treatment in elderly patients with acute myeloid leukemia (EFFIKIR trial).. Journal of Clinical Oncology. 31(15_suppl). TPS3117–TPS3117. 3 indexed citations

Huguet, Françoise, et al.. (2010). L-asparaginase for adult CD20 positive B-cell precursor acute lymphoblastic leukemia. Haematologica. 95(6). 1042–1042. 2 indexed citations

Huguet, F., Thibaut Leguay, Francis Lacombe, et al.. (2009). Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia. Haematologica. 95(2). 324–328. 71 indexed citations

Etienne, A., Pascal Turlure, Thierry de Revel, et al.. (2008). Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia. Haematologica. 93(12). 1806–1813. 106 indexed citations

Pendino, Frédéric, Josette Hillion, Charles Dudognon, et al.. (2006). Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL. Leukemia. 20(4). 599–603. 13 indexed citations

Vey, Norbert, André Bosly, Agnès Guerci, et al.. (2006). Arsenic Trioxide in Patients With Myelodysplastic Syndromes: A Phase II Multicenter Study. Journal of Clinical Oncology. 24(16). 2465–2471. 69 indexed citations

Tallman, Martin S., Benjamin Brenner, Javier de la Serna, et al.. (2005). Meeting report. Leukemia Research. 29(3). 347–351. 37 indexed citations

10.

Asnafi, Vahid, Agnès Buzyn, Xavier Thomas, et al.. (2005). Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study. Blood. 105(8). 3072–3078. 41 indexed citations

11.

Dhédin, Nathalie, Hervé Dombret, Xavier Thomas, et al.. (2005). Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials. Leukemia. 20(2). 336–344. 28 indexed citations

12.

Silva, Nicolas Da, Sandrine Meyer‐Monard, Antonio Parrado, et al.. (2000). Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO. The Hematology Journal. 1(5). 316–328. 15 indexed citations

13.

Delva, Laurent, Patricia Renesto, N Balitrand, et al.. (1996). All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemia.. PubMed. 10(1). 95–101. 29 indexed citations

14.

Rio, Bernard, Christophe Louvet, Antoine Gessain, et al.. (1990). [Adult T-cell leukemia and non-malignant adenopathies associated with HTLV I virus. Apropos of 17 patients born in the Caribbean region and Africa].. PubMed. 19(16). 746–51. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact